Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 25% in morning…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/immunomes-tumor-drug-meets-main-goal-late-stage-study-2025a1000z4c?src=rss
Author :
Publish date : 2025-12-15 12:16:00
Copyright for syndicated content belongs to the linked Source.
